Maolin Wang

Shantou, 515041, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Spatiotemporally programmed hybrid nano-prodrugs orchestrate multidimensionally synergistic cascade lethality in NSCLC.

Spatiotemporally programmed hybrid nano-prodrugs orchestrate multidimensionally synergistic cascade lethality in NSCLC.

Journal: Theranostics
Published: March 27, 2026

Betulinic Acid Self-Assembled Nanodelivery System Attenuates Osteoarthritis by Dually Modulating Macrophage Polarization and Macrophage-Chondrocyte Crosstalk via Disruption of the GSK3β/NF-κB/CCL20 Axis.

Betulinic Acid Self-Assembled Nanodelivery System Attenuates Osteoarthritis by Dually Modulating Macrophage Polarization and Macrophage-Chondrocyte Crosstalk via Disruption of the GSK3β/NF-κB/CCL20 Axis.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 04, 2025

Engineering selective PI3Kγ inhibitors with antitumor and immunomodulatory potentials.

Engineering selective PI3Kγ inhibitors with antitumor and immunomodulatory potentials.

Journal: Acta pharmaceutica Sinica. B
Published: July 04, 2025

Voacamine initiates the PI3K/mTOR/Beclin1 pathway to induce autophagy and potentiate apoptosis in acute myeloid leukemia.

Voacamine initiates the PI3K/mTOR/Beclin1 pathway to induce autophagy and potentiate apoptosis in acute myeloid leukemia.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 02, 2024

The different functions of V-ATPase subunits in adipocyte differentiation and their expression in obese mice.

The different functions of V-ATPase subunits in adipocyte differentiation and their expression in obese mice.

Journal: Biochemical and biophysical research communications
Published: September 10, 2024

Targeting Ferroptosis as an Advance Strategy in Cancer Therapy.

Targeting Ferroptosis as an Advance Strategy in Cancer Therapy.

Journal: Antioxidants & redox signaling
Published: July 03, 2024

Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer.

Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 07, 2024

Advances in nano-preparations for improving tetrandrine solubility and bioavailability.

Advances in nano-preparations for improving tetrandrine solubility and bioavailability.

Journal: Archiv der Pharmazie
Published: April 12, 2024

N-heterocyclic carbene catalyzed [2 + 3] annulation reaction for the synthesis of trifluoroethyl 3,2'-spirooxindole γ-lactam.

N-heterocyclic carbene catalyzed [2 + 3] annulation reaction for the synthesis of trifluoroethyl 3,2'-spirooxindole γ-lactam.

Journal: RSC advances
Published: March 24, 2024

Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mTOR pathway.

Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mTOR pathway.

Journal: Bioorganic chemistry
Published: November 13, 2023

Bruceine A: Suppressing metastasis via MEK/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer.

Bruceine A: Suppressing metastasis via MEK/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 11, 2023

Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.

Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.

Journal: Cancer research
Published: June 20, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026